双膦酸盐在根管治疗中的临床影响。
Clinical impact of bisphosphonates in root canal therapy.
作者信息
AlRahabi Mothanna K, Ghabbani Hani M
机构信息
College of Dentistry, Taibah University, Madinah Al Munawwarah, Kingdom of Saudi Arabia. E-mail.
出版信息
Saudi Med J. 2018 Mar;39(3):232-238. doi: 10.15537/smj.2018.3.20923.
Abstract
Bisphosphonates are stable structural analogs of pyrophosphate, which suppress the activity of osteoclasts, leading to decreased bone resorption. They are essential medications in the treatment of osteoporosis. Osteonecrosis of the jaw is a serious adverse effect of bisphosphonate therapy. The prevalence of bisphosphonate-related osteonecrosis of the jaw varies from 0% to 28%, and it can be triggered by dental extraction and trauma. Root canal therapy can delay, or even eliminate, the need for tooth extraction, and therefore, may reduce the risk of bisphosphonate-related osteonecrosis of the jaw. We suggest that this might be the best treatment for teeth with pulpal and/or periapical disease.
摘要
双膦酸盐是焦磷酸盐的稳定结构类似物，可抑制破骨细胞的活性，从而减少骨吸收。它们是治疗骨质疏松症的重要药物。颌骨坏死是双膦酸盐治疗的一种严重不良反应。双膦酸盐相关颌骨坏死的发生率在0%至28%之间，可由拔牙和创伤引发。根管治疗可以延迟甚至消除拔牙的必要性，因此可能降低双膦酸盐相关颌骨坏死的风险。我们认为这可能是治疗牙髓和/或根尖周疾病牙齿的最佳方法。
相似文献
1
Clinical impact of bisphosphonates in root canal therapy.双膦酸盐在根管治疗中的临床影响。
Saudi Med J. 2018 Mar;39(3):232-238. doi: 10.15537/smj.2018.3.20923.
2
Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.去除基质结合唑来膦酸可通过挽救破骨细胞功能来预防拔牙后颌骨坏死。
Bone. 2018 May;110:141-149. doi: 10.1016/j.bone.2018.01.030. Epub 2018 Feb 9.
3
Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.长期口服双膦酸盐会延迟拔牙后愈合：单机构前瞻性研究。
Osteoporos Int. 2018 Oct;29(10):2315-2321. doi: 10.1007/s00198-018-4621-7. Epub 2018 Jul 2.
4
Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.既往根尖周炎症状态会加重拔牙诱导的小鼠双膦酸盐相关颌骨坏死病变。
J Endod. 2016 Nov;42(11):1641-1646. doi: 10.1016/j.joen.2016.07.020. Epub 2016 Sep 13.
5
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究，探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素：原发伤口闭合和药物暂停真的能预防 MRONJ 吗？
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
6
[Bisphosphonate-related osteonecrosis of the jaw].[双膦酸盐相关颌骨坏死]
Semergen. 2014 Apr;40(3):143-8. doi: 10.1016/j.semerg.2013.05.005. Epub 2013 Sep 1.
7
8
[Focus: Drug-related osteonecrosis of the jaw].[聚焦：药物相关性颌骨坏死]
Presse Med. 2018 Jan;47(1):19-33. doi: 10.1016/j.lpm.2017.10.009. Epub 2017 Dec 21.
9
[A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].[一例接受静脉注射双膦酸盐治疗的患者发生双膦酸盐相关颌骨坏死]
Gan To Kagaku Ryoho. 2014 Feb;41(2):225-7.
10
Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.拔牙作为癌症患者双膦酸盐相关颌骨坏死的危险因素：最新进展
Odontostomatol Trop. 2013 Jun;36(142):38-46.
引用本文的文献
1
Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis.牙髓治疗与颌骨药物性骨坏死的发病：一项范围综述和基于专家意见的定性元分析。
BMC Oral Health. 2025 Aug 23;25(1):1362. doi: 10.1186/s12903-025-06741-5.
2
Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).颌骨药物性骨坏死（MRONJ）预防与管理策略的综合综述
Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.
3
Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws.双膦酸盐及其与牙科手术的关联：探索双膦酸盐相关颌骨坏死
Cancers (Basel). 2023 Nov 10;15(22):5366. doi: 10.3390/cancers15225366.
4
AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption.AS-605240 通过抑制骨吸收来缓解骨质疏松症。
Drug Des Devel Ther. 2023 Apr 27;17:1275-1288. doi: 10.2147/DDDT.S403231. eCollection 2023.
5
Clinical values of serum Semaphorin 4D (Sema4D) in medication‑related osteonecrosis of the jaw.血清 Semaforin 4D（Sema4D）在药物相关性颌骨坏死中的临床价值。
Eur J Med Res. 2023 Mar 30;28(1):140. doi: 10.1186/s40001-023-01095-6.
6
Spontaneous Bisphosphonate-related Osteonecrosis Associated with a Tooth that Had a Necrotic Pulp: A Case Report.与牙髓坏死牙齿相关的自发性双膦酸盐相关骨坏死：一例报告
Iran Endod J. 2020 Summer;15(3):188-194. doi: 10.22037/iej.v15i3.27849.
7
The role of bisphosphonates in orthodontic tooth movement-A review.双膦酸盐在正畸牙齿移动中的作用——综述
J Family Med Prim Care. 2019 Dec 10;8(12):3783-3788. doi: 10.4103/jfmpc.jfmpc_825_19. eCollection 2019 Dec.
8
Dental care for patients taking antiresorptive drugs: a literature review.服用抗骨吸收药物患者的口腔护理：文献综述
Restor Dent Endod. 2019 Nov 1;44(4):e42. doi: 10.5395/rde.2019.44.e42. eCollection 2019 Nov.
9
Root canal treatment in elderly patients: A review and clinical considerations.老年患者的根管治疗：综述与临床考量
Saudi Med J. 2019 Mar;40(3):217-223. doi: 10.15537/smj.2019.3.23769.
本文引用的文献
1
AAE Position Statement: AAE Guidance on the Use of Systemic Antibiotics in Endodontics.美国牙髓病学会立场声明：美国牙髓病学会关于牙髓病学中全身用抗生素使用的指南。
J Endod. 2017 Sep;43(9):1409-1413. doi: 10.1016/j.joen.2017.08.015.
2
Evaluation of the accuracy of nine electronic apex locators by using Micro-CT.利用 Micro-CT 评估九种电子根尖定位仪的准确性。
Int Endod J. 2018 Feb;51(2):223-232. doi: 10.1111/iej.12814. Epub 2017 Jul 26.
3
Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index.口服双膦酸盐治疗期间发生骨折与骨材料强度指数恶化有关。
Bone. 2017 Oct;103:64-69. doi: 10.1016/j.bone.2017.06.018. Epub 2017 Jun 24.
4
[BISPHOSPHONATES AND OCULAR INFLAMMATION].
Harefuah. 2017 Feb;156(2):71-73.
5
UK clinical guideline for the prevention and treatment of osteoporosis.英国临床指南：骨质疏松症的预防和治疗。
Arch Osteoporos. 2017 Dec;12(1):43. doi: 10.1007/s11657-017-0324-5. Epub 2017 Apr 19.
6
Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.非典型双膦酸盐相关股骨近端骨折患者的回顾性研究。
Injury. 2017 Jun;48(6):1159-1164. doi: 10.1016/j.injury.2017.03.025. Epub 2017 Apr 4.
7
Radiographic evidence of treatment with bisphosphonates.双膦酸盐治疗的影像学证据。
Br Dent J. 2017 Apr 7;222(7):507-510. doi: 10.1038/sj.bdj.2017.307.
8
Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.与接受唑来膦酸或伊班膦酸静脉首剂量治疗的初治或预处理骨质疏松症女性的急性期反应相关的因素。
Osteoporos Int. 2017 Jun;28(6):1995-2002. doi: 10.1007/s00198-017-3992-5. Epub 2017 Mar 15.
9
Association between Systemic Diseases and Endodontic Outcome: A Systematic Review.全身疾病与牙髓治疗结果之间的关联：一项系统评价
J Endod. 2017 Apr;43(4):514-519. doi: 10.1016/j.joen.2016.11.008. Epub 2017 Feb 9.
10
Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates.口服和静脉注射双膦酸盐治疗患者管理方案中的预防措施及抗生素治疗
J Clin Exp Dent. 2017 Jan 1;9(1):e141-e149. doi: 10.4317/jced.53372. eCollection 2017 Jan.
Zotero 插件